Roundup Weedkiller Cancer Lawsuit: See If You Qualify for Compensation
Bayer/Monsanto's Roundup herbicide has been at the center of one of the largest mass tort cases in U.S. history. In February 2026, Bayer announced a proposed $7.25 billion settlement for current and future non-Hodgkin lymphoma claims. If you used Roundup regularly and have been diagnosed with lymphoma, you may have a claim worth pursuing.
What Is the Roundup Cancer Controversy?
Roundup is the world's most widely used weedkiller, manufactured by Monsanto and now owned by Bayer. Its active ingredient, glyphosate, has been used in agriculture, landscaping, and home gardens since 1974. In 2015, the International Agency for Research on Cancer (IARC) - part of the World Health Organization - classified glyphosate as "probably carcinogenic to humans" (Group 2A), based primarily on evidence linking it to non-Hodgkin lymphoma.
Tens of thousands of lawsuits have been filed against Bayer/Monsanto by people who used Roundup regularly and were later diagnosed with non-Hodgkin lymphoma. Bayer has paid approximately $11 billion across roughly 100,000 previously resolved cases since 2018 while continuing to sell Roundup in the U.S.
On February 17, 2026, Bayer announced a proposed $7.25 billion global class settlement to resolve current and future non-Hodgkin lymphoma claims over a 21-year program. The U.S. District Court for the Northern District of California granted preliminary approval in March 2026, and a final approval decision is expected in mid-2026. The proposed settlement is designed to provide a streamlined path to compensation for eligible claimants.
Separately, the U.S. Supreme Court granted certiorari in a $1.25 million Missouri Roundup verdict to decide whether federal pesticide labeling law (FIFRA) preempts state-law failure-to-warn claims. A ruling is expected in June 2026 and could materially reshape remaining Roundup litigation. New claimants are still being accepted, and Roundup MDL 2741 has thousands of cases pending as of April 2026.
Who May Qualify for a Roundup Lawsuit?
You may qualify if you used Roundup or other glyphosate-based herbicides regularly and have been diagnosed with non-Hodgkin lymphoma or a related lymphoma.
You May Qualify If You:
- Used Roundup or other glyphosate-based herbicides regularly for farming or agricultural work
- Worked as a landscaper, groundskeeper, golf course worker, or nursery employee with regular Roundup use
- Used Roundup regularly at home for weed control for 2 or more years
- Have been diagnosed with non-Hodgkin lymphoma or a related form of lymphoma
The Science: IARC and Glyphosate
The IARC classification of glyphosate as "probably carcinogenic" (Group 2A) in 2015 was based on "limited evidence" of cancer in humans and "sufficient evidence" of cancer in experimental animals. This classification has been contested by Bayer and some regulatory bodies, including the U.S. EPA, which has maintained that glyphosate is not likely carcinogenic when used as directed. The divergence between regulatory agencies and IARC has been central to Roundup litigation. Courts have allowed plaintiffs to present evidence based on the IARC classification and other studies. The science remains actively debated.
Settlements and Ongoing Litigation
Bayer agreed to pay approximately $10.9 billion starting in 2020 to resolve the majority of then-pending Roundup cases, and has paid cumulatively around $11 billion across approximately 100,000 resolved cases. On February 17, 2026, Bayer announced an additional proposed $7.25 billion global class settlement to resolve current and future NHL claims over a 21-year period; preliminary approval was granted in March 2026, with final approval decision expected mid-2026. Importantly, Bayer continues to face new lawsuits, and courts have historically rejected attempts to limit future litigation. The Supreme Court is expected to rule on a related federal preemption question in June 2026. New claimants are being accepted.
Why Claimants Choose UnitedClaimsBureau
UCB connects claimants with experienced mass tort attorneys at no upfront cost. Here is what to expect when you work with us.
Farmers, Workers & Homeowners
Whether you used Roundup professionally for years or as a regular homeowner, our case review process is designed to quickly assess whether your exposure history and diagnosis meet current litigation criteria.
Roundup-Experienced Attorneys
Attorneys in our network have specific experience with Roundup/glyphosate litigation and understand the evidence needed to build a compelling case against Bayer/Monsanto.
Contingency Representation
Attorneys in our network work on a contingency fee basis. Your ability to pursue justice should never depend on your financial situation.
Active Litigation
Roundup litigation is ongoing. New claims are being accepted. If you haven't come forward yet, it's not too late - but filing deadlines vary by state, so act promptly.
Frequently Asked Questions
What is the connection between Roundup and cancer?
Who qualifies to file a Roundup lawsuit?
What type of cancer qualifies for a Roundup claim?
Has Bayer settled Roundup cases?
What is the February 2026 Roundup settlement?
What is the Supreme Court case about Roundup?
Can I still file if Bayer has already paid settlements?
How long do I have to file a Roundup lawsuit?
What compensation can Roundup cancer victims recover?
Do I need to prove I used only Roundup, not other pesticides?
Used Roundup and Diagnosed With Lymphoma?
You may have a legal claim for compensation. Bayer has paid approximately $11 billion to resolve Roundup claims to date and announced a proposed $7.25 billion global settlement in February 2026 covering current and future claimants. Find out if you qualify with a confidential, no-obligation case review.
Start Your Case Review